Indivior Inc.
- UEI
- VLCNBHCXCCJ9
- CAGE
- 7Z9E7
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Deleted
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- indivior.com
- Founded
- 1994
- Employees
- 251-1K
- Estimated annual revenue
- $500M-$1B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $2,271,744 |
| FY2025 | $9,332,650 |
| FY2024 | $11,190,536 |
| FY2023 | $32,379,816 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $2,271,744 |
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Braeburn Inc. | Plymouth Meeting, PA | 325412 Pharmaceutical Preparation Manufacturing |
| U.s. Division | Rockville, MD | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Mallinckrodt Pharmaceuticals | Webster Groves, MO | 325412 Pharmaceutical Preparation Manufacturing |
| Murty Pharmaceuticals, Inc. | Lexington, KY | 325412 Pharmaceutical Preparation Manufacturing |
| Astellas Pharma US, Inc. | Northbrook, IL | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Indivior Inc. is a for-profit pharmaceutical manufacturer based in Richmond, Virginia, specializing in developing treatments for opioid use disorder and overdose prevention. Registered in SAM.gov since October 2017, the company provides critical pharmaceutical products to federal agencies, focusing on medications and drug-device combination products related to addiction and substance abuse treatment. The company has established itself as a key supplier of specialized pharmaceutical solutions to various federal healthcare and correctional institutions.
Through federal contract awards, Indivior Inc. has secured significant contracts with agencies like the Department of Health and Human Services and the Department of Veterans Affairs. The company's most notable recent contract is a $113.8 million cost-plus-fixed-fee agreement with the Office of the Assistant Secretary for Preparedness and Response to provide an intranasal nalmefene drug-device combination product for treating opioid overdoses. Additionally, Indivior has received delivery orders from the United States Penitentiary Leavenworth for controlled and medication-assisted treatment (MAT) medications, with contract values ranging from $44 to $5,200. These contracts demonstrate the company's expertise in developing pharmaceutical interventions for opioid-related medical challenges, with no specific set-aside designations applied to their awards.
Indivior Inc. holds a significant Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs, valued at $131.9 million, which runs through June 2025. This multiple-award contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB) allows the VA to procure drugs, pharmaceuticals, and hematology-related products. The IDV covers a broad range of medical supplies, with Indivior previously receiving delivery orders for its Sublocade medication to treat opioid use disorder. The company has also received research grants from the National Institute on Drug Abuse, totaling over $8 million, to conduct clinical evaluations and develop non-opioid treatments for substance use disorders. This comprehensive federal contract portfolio positions Indivior as a critical provider of specialized pharmaceutical solutions to federal healthcare systems.
Quick answers
Is Indivior Inc. registered in SAM.gov?
Indivior Inc.'s SAM.gov registration was deleted on March 18, 2017.
What is Indivior Inc.'s CAGE code?
Indivior Inc.'s CAGE code is 7Z9E7, and its Unique Entity ID (UEI) is VLCNBHCXCCJ9.
Which contract vehicles does Indivior Inc. hold?
Indivior Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Indivior Inc. received in federal contracts?
Federal contracts obligated $9,332,650 to Indivior Inc. in fiscal year 2025 and $55,174,746 in fiscal years 2023 through 2027.
How does Indivior Inc. rank among federal contractors?
Indivior Inc. ranked #10 in PSC AN11, #24 in NAICS 325412 and #32 in NAICS 3254 in FY2025.
What is Indivior Inc.'s most recent federal award?
Indivior Inc.'s most recent federal contract award is Mckesson mat medications MAR 25 (15B40825F00000082), from United States Penitentiary Leavenworth (BOP), on January 1, 2025.
On GovTribe
See Indivior Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors